Office REITs shift to the OCR as tenants hunt for cheaper rents

Are they leaving the CBD?

According to Maybank Kim Eng, the impact of office supply from Outside Central Region (OCR) on CBD rentals should not be ignored.

Here's more:

We cannot rule out the possibility of high-quality decentralised developments like Westgate Tower in Jurong, Mapletree Business City Phase 1 at Pasir Panjang Road and The Metropolis at Buona Vista drawing tenants (albeit smaller floor-plate at times) away from CBD office buildings.

Already, Mapletree Business City has attracted big names such as Deutsche Bank, HSBC, Credit Agricole,Unilever, Nike, Toshiba and Samsung Asia, while potential tenants at The Metropolis include Shell, NOL, Procter & Gamble and GlaxoSmithKline.

And within the CBD, a hollowing out could occur when tenants exit buildings earmarked for en bloc redevelopment (possibly The Arcade at Raffles Place in the near term), sparking further substantial declines in Grade B office rentals. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare